{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SOD1", "autophagy", "breast cancer", "cell death", "chebulinic acid", "epithelial-mesenchymal transition"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32902904", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "09"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1002/cbin.11463"], "Journal": {"ISSN": "1095-8355", "JournalIssue": {"Volume": "44", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Cell biology international", "ISOAbbreviation": "Cell Biol Int"}, "ArticleTitle": "Chebulinic acid inhibits MDA-MB-231 breast cancer metastasis and promotes cell death through down regulation of SOD1 and induction of autophagy.", "Pagination": {"StartPage": "2553", "EndPage": "2569", "MedlinePgn": "2553-2569"}, "Abstract": {"AbstractText": ["Triple-negative breast cancers (TNBC) are highly aggressive and drug resistant accounting for majority of cases with poor outcome. Purified natural compounds display substantial anticancer activity with reduced cytotoxicity providing a new avenue to combat TNBC. Chebulinic acid (CA), a polyphenol derived from the fruits of various medicinal plants has potent anticancer activity. Here, we demonstrate that CA shows significant cytotoxicity against triple negative MDA-MB-231 cells. CA exhibited cytotoxicity to MDA-MB-231 cells in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Further, CA mitigated MDA-MB-231 cells viability and proliferation as shown by reduced live cell count, crystal violet staining, colony formation assay, soft agar assay and cell cycle analysis. Wound healing assay and trans-well migration assay demonstrated that CA significantly inhibited migration of MDA-MB-231 cells. Also reduced MMP9 expression was observed in CA-treated cells by gelatin zymography. CA negatively regulated mesenchymal characteristics of MDA-MB-231 cells demonstrated by F-actin staining and reduced expression of N-cadherin by confocal microscopy and western blot analysis. Annexin V/propidium iodide (PI) and active caspase-3 staining showed that CA was able to induce apoptosis in MDA-MB-231 cells but did not activate caspase-3. Two-dimensional gel electrophoresis based proteomic analysis demonstrated that CA regulated proteins belonging to the oxidative stress pathway, apoptotic pathway and proteins with antiproliferative activity. Western blot analysis analysis revealed that CA negatively regulated superoxide dismutase 1 (SOD1) and enhanced oxidative stress in MDA-MB-231 cells. SOD1 in-gel activity assay also showed reduced SOD1 activity upon CA treatment. Overexpression studies with GFP-LC3 and tandem tagged RFP-GFP-LC-3 also demonstrated enhanced autophagy upon CA treatment."], "CopyrightInformation": "\u00a9 2020 International Federation for Cell Biology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India."}], "LastName": "Sharma", "ForeName": "Akshay", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India."}], "LastName": "Mishra", "ForeName": "Tripti", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India."}], "LastName": "Thacker", "ForeName": "Gatha", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India."}], "LastName": "Mishra", "ForeName": "Mukul", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India."}], "LastName": "Narender", "ForeName": "Tadigoppula", "Initials": "T"}, {"Identifier": ["0000-0002-6316-0947"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India."}], "LastName": "Trivedi", "ForeName": "Arun Kumar", "Initials": "AK"}], "GrantList": [{"GrantID": "MLP0019", "Agency": "Central Drug Research Institute", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Biol Int", "NlmUniqueID": "9307129", "ISSNLinking": "1065-6995"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydrolyzable Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "SOD1 protein, human"}, {"RegistryNumber": "18942-26-2", "NameOfSubstance": "chebulinic acid"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase-1"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["genetics"], "DescriptorName": "Autophagy"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["genetics"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Hydrolyzable Tannins"}, {"QualifierName": ["genetics"], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["methods"], "DescriptorName": "Proteomics"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase-1"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Triple Negative Breast Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aita V. M., Liang X. H., Murty V. V. V. S., Pincus D. L., Yu W., Cayanis E., \u2026 Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999;59:59-65."}, {"Citation": "Alfei S., Marengo B., Zuccari G., Turrini F., Domenicotti C. Dendrimer nanodevices and gallic acid as novel strategies to fight chemoresistance in neuroblastoma cells. Nanomaterials, 2020.10, 1243."}, {"Citation": "Alhakamy, N. A., Ahmed, O. A. A., Kurakula, M., Caruso, G., Caraci, F., Asfour, H. Z., \u2026 Abdel-Naim, A. B. (2020). Chitosan-based microparticles enhance ellagic acid's colon targeting and proapoptotic activity. Pharmaceutics, 12(7), 652."}, {"Citation": "Al-Mahmood S., Sapiezynski J., Garbuzenko O. B., Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Delivery and Translational Research. 2018;8:1483-1507."}, {"Citation": "Andreopoulou E., Schweber S. J., Sparano J. A., McDaid H. M. Therapies for triple negative breast cancer. Expert Opinion on Pharmacotherapy 2015;16:983-998."}, {"Citation": "Athira A. P., Abhinand C. S., Saja K., Helen A., Reddanna P., Sudhakaran P. R. Anti-angiogenic effect of chebulagic acid involves inhibition of the VEGFR2- and GSK-3beta-dependent signaling pathways. Biochemistry and Cell Biology 2017;95:563-570."}, {"Citation": "Banks C. J., Andersen J. L. Mechanisms of SOD1 regulation by posttranslational modifications. Redox Biology 2019;26:101270."}, {"Citation": "Borowicz S., Van Scoyk M., Avasarala S., Karuppusamy Rathinam M. K., Tauler J., Bikkavilli R. K., Winn R. A. The soft agar colony formation assay. Journal of Visualized Experiments: JoVE 2014:e51998."}, {"Citation": "Brown D. P., Chin-Sinex H., Nie B., Mendonca M. S., Wang M. Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer. Cancer Chemotherapy and Pharmacology 2009;63:723-730."}, {"Citation": "Chen Y., McMillan-Ward E., Kong J., Israels S. J., Gibson S. B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death and Differentiation 2008;15:171-182."}, {"Citation": "Chhabra S., Mishra T., Kumar Y., Thacker G., Kanojiya S., Chattopadhyay N., \u2026 Trivedi A. K. Chebulinic acid isolated from the fruits of terminalia chebula specifically induces apoptosis in acute myeloid leukemia cells. Phytotherapy Research 2017;31:1849-1857."}, {"Citation": "Duan J., Li Y., Gao H., Yang D., He X., Fang Y., Zhou G. Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer. Food & Function, 2020.11:6332-6339."}, {"Citation": "Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., \u2026 Bray F. Cancer incidence and mortality worldwide: Sources, methods, and major patterns in GLOBOCAN 2012. International Journal of Cancer 2014;136:E359-E386."}, {"Citation": "Godone R. L. N., Leitao G. M., Araujo N. B., Castelletti C. H. M., Lima-Filho J. L., Martins D. B. G. Clinical and molecular aspects of breast cancer: Targets and therapies. Biomedicine & Pharmacotherapy\u2009=\u2009Biom\u00e9decine & Pharmacoth\u00e9rapie 2018;106:14-34."}, {"Citation": "Gomez, M. L., Shah, N., Kenny, T. C., Jenkins, E. C., & Germain, D. (2019). SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation. Oncogene, 38, 5751-5765."}, {"Citation": "G\u00f3mez-Miragaya J., Palafox M., Par\u00e9 L., Yoldi G., Ferrer I., Vila S., \u2026 Gonz\u00e1lez-Su\u00e1rez E. Resistance to Taxanes in triple-negative breast cancer associates with the dynamics of a CD49f+ tumor-initiating population. Stem Cell Reports. 2017;8:1392-1407."}, {"Citation": "Hasan M., Leak R. K., Stratford R. E., Zlotos D. P., Witt-Enderby P. A. Drug conjugates-an emerging approach to treat breast cancer. Pharmacology Research & Perspectives 2018;6:e00417."}, {"Citation": "Jang Y. G., Ko E. B., Choi K. C. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression. Journal of Nutritional Biochemistry, 2020.84:108444."}, {"Citation": "Johnson J. J., Bailey H. H., Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: A translational perspective. Phytomedicine 2010;17:3-13."}, {"Citation": "Justus C. R., Leffler N., Ruiz-Echevarria M., Yang L. V. In vitro cell migration and invasion assays. Journal of Visualized Experiments: JoVE 2014."}, {"Citation": "Kapoor I., Kanaujiya J., Kumar Y., Thota J. R., Bhatt M. L. B., Chattopadhyay N., \u2026 Trivedi A. K. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation. Oncotarget 2016;7:7640-7656."}, {"Citation": "Kar I., Chattopadhyaya R. Effect of seven Indian plant extracts on Fenton reaction-mediated damage to DNA constituents. Journal of Biomolecular Structure and Dynamics 2016;35:2997-3011."}, {"Citation": "Karlsson G., Nygren P., Glimelius B. Economic aspects of chemotherapy. Acta Oncologica 2001;40:412-433."}, {"Citation": "Khan T., Sankhe K., Suvarna V., Sherje A., Patel K., Dravyakar B. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy\u2009=\u2009Biom\u00e9decine & Pharmacoth\u00e9rapie 2018;103:923-938."}, {"Citation": "Kim H. J., Kim J., Kang K. S., Lee K. T., Yang H. O. Neuroprotective effect of chebulagic acid via autophagy induction in SH-SY5Y cells. Biomolecules & Therapeutics. 2014;22:275-281."}, {"Citation": "Kim J. W., Sahm H., You J., Wang M. Knock-down of superoxide dismutase 1 sensitizes cisplatin-resistant human ovarian cancer cells. Anticancer Research 2010;30:2577-2581."}, {"Citation": "Kumar N., Gangappa D., Gupta G., Karnati R. Chebulagic acid from terminalia chebula causes G1 arrest, inhibits NFkappaB and induces apoptosis in retinoblastoma cells. BMC Complementary and Alternative Medicine, 2014.14:319."}, {"Citation": "Kupai K., Szucs G., Cseh S., Hajdu I., Csonka C., Csont T., Ferdinandy P. Matrix metalloproteinase activity assays: Importance of zymography. Journal of Pharmacological Toxicol Methods 2010;61:205-209."}, {"Citation": "Lee K., Hart M. R., Briehl M. M., Mazar A. P., Tome M. E. The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma. International Journal of Oncology 2014;45:439-447."}, {"Citation": "Li M., Liu J., Li S., Feng Y., Yi F., Wang L., \u2026 Cao L. Autophagy-related 7 modulates tumor progression in triple-negative breast cancer. Laboratory Investigation 2019;99:1266-1274."}, {"Citation": "Li X., Chen Y., Zhao J., Shi J., Wang M., Qiu S., \u2026 Liu C. The specific inhibition of SOD1 selectively promotes apoptosis of cancer cells via regulation of the ROS signaling network. Oxidative Medicine and Cellular Longevity 2019;2019:9706792-21."}, {"Citation": "Lin S. R., Chang C. H., Hsu C. F., Tsai M. J., Cheng H., Leong M. K., \u2026 Weng C. F. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. British Journal of Pharmacology 2019;177:1409-23."}, {"Citation": "Liu S., Li B., Xu J., Hu S., Zhan N., Wang H., \u2026 Xu X. SOD1 promotes cell proliferation and metastasis in non-small cell lung cancer via an miR-409-3p/SOD1/SETDB1 epigenetic regulatory feedforward loop. Frontiers in Cell and Developmental Biology 2020;8:213."}, {"Citation": "Lochab S., Pal P., Kapoor I., Kanaujiya J. K., Sanyal S., Behre G., Trivedi A. K. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation. Biochimica et Biophysica Acta/General Subjects 2013;1833:2639-2652."}, {"Citation": "Lodi A., Saha A., Lu X., Wang B., Sentandreu E., Collins M., \u2026 Tiziani S. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. NPJ Precision Oncology. 2017;1, 18."}, {"Citation": "Lopez A., Fleming A., Rubinsztein D. C. Seeing is believing: methods to monitor vertebrate autophagy in vivo. Open Biology 2018;8, 180106."}, {"Citation": "Lu K., Chakroborty D., Sarkar C., Lu T., Xie Z., Liu Z., Basu S. Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. PLOS One. 2012;7:e43934."}, {"Citation": "Mathiasen I. S., Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends in Molecular Medicine 2002;8:212-220."}, {"Citation": "Mittal A., Piyathilake C., Hara Y., Katiyar S. K. Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: Relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003;5:555-565."}, {"Citation": "Mocanu M. M., Nagy P., Szollosi J. Chemoprevention of breast cancer by dietary polyphenols. Molecules 2015;20:22578-22620."}, {"Citation": "Mohammed Saleem Y. I., Selim M. I. MDM2 as a target for ellagic acidmediated suppression of prostate cancer cells in vitro. Oncology Reports, 2020.44:1255-1265."}, {"Citation": "Mokhtari R. B., Homayouni T. S., Baluch N., Morgatskaya E., Kumar S., Das B., Yeger H. Combination therapy in combating cancer. Oncotarget 2017;8:38022-38043."}, {"Citation": "Pal P., Kanaujiya J. K., Lochab S., Tripathi S. B., Bhatt M. L. B., Singh P. K., \u2026 Trivedi A. K. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562. Proteomics 2011;11:1517-1529."}, {"Citation": "Pan M. H., Chiou Y. S., Chen L. H., Ho C. T. Breast cancer chemoprevention by dietary natural phenolic compounds: specific epigenetic related molecular targets. Molecular Nutrition & Food Research 2015;59:21-35."}, {"Citation": "Papa L., Manfredi G., Germain D. SOD1, an unexpected novel target for cancer therapy. Genes Cancer. 2014;5:15-21."}, {"Citation": "Patra, S., Bhol, C. S., Panigrahi, D. P., Praharaj, P. P., Pradhan, B., Jena, M., & Bhutia, S. K. (2020). Gamma irradiation promotes chemo-sensitization potential of gallic acid through attenuation of autophagic flux to trigger apoptosis in NRF2 inactivation signalling pathway. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2020.06.022"}, {"Citation": "Perou C. M., S\u00f8rlie T., Eisen M. B., van de Rijn M., Jeffrey S. S., Rees C. A., \u2026 Botstein D. Molecular portraits of human breast tumours. Nature 2000;406:747-752."}, {"Citation": "Prat A., Pineda E., Adamo B., Galv\u00e1n P., Fern\u00e1ndez A., Gaba L., \u2026 Mu\u00f1oz M. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 2015;24 Suppl 2:S26-S35."}, {"Citation": "Priyadarshi, K., Shirsath, K., Waghela, N. B., Sharma, A., Kumar, A., & Pathak, C. (2020). Surface modified PAMAM dendrimers with gallic acid inhibit, cell proliferation, cell migration and inflammatory response to augment apoptotic cell death in human colon carcinoma cells. Journal of Biomolecular Structure and Dynamics, 1-17."}, {"Citation": "Rafehi H., Orlowski C., Georgiadis G. T., Ververis K., El-Osta A., Karagiannis T. C. Clonogenic assay: adherent cells. Journal of Visualized Experiments: JoVE 2011."}, {"Citation": "Reddy D. B., Reddy T. C. M., Jyotsna G., Sharan S., Priya N., Lakshmipathi V., Reddanna P. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of terminalia chebula retz., induces apoptosis in COLO-205 cell line. Journal of Ethnopharmacology 2009;124:506-512."}, {"Citation": "Rice S., Whitehead S. A. Phytoestrogens and breast cancer--promoters or protectors? Endocrine-related Cancer 2006;13:995-1015."}, {"Citation": "Saleem A., Husheem M., Harkonen P., Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of terminalia chebula retz. fruit. Journal of Ethnopharmacology 2002;81:327-336."}, {"Citation": "Shah S. P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., \u2026 Aparicio S. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012;486:395-399."}, {"Citation": "Shanmuganathan S., Angayarkanni N. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNF alpha induced proangiogenic and proinflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation. Vascular pharmacology 2018;108:23-35."}, {"Citation": "Shaw F. L., Harrison H., Spence K., Ablett M. P., Sim\u00f5es B. M., Farnie G., Clarke R. B. A detailed mammosphere assay protocol for the quantification of breast stem cell activity. Journal of Mammary Gland Biology and Neoplasia 2012;17:111-117."}, {"Citation": "Shi Y., Sahu R. P., Srivastava S. K. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer. 2008;8:294."}, {"Citation": "Song I. S., Jeong Y. J., Park J. H., Shim S., Jang S. W. Chebulinic acid inhibits smooth muscle cell migration by suppressing PDGF-Rbeta phosphorylation and inhibiting matrix metalloproteinase-2 expression. Scientific Reports 2017;7:11797."}, {"Citation": "Sunar V., H. TD, Sarici F., Ates O., Akin S., Baspinar B., et al. Association between androgen receptor status and prognosis in triple negative breast cancer. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology 2018;23:1325-1330."}, {"Citation": "Tarasiuk A., Mosinska P., Fichna J. Triphala: Current applications and new perspectives on the treatment of functional gastrointestinal disorders. Chinese Medicine 2018;13:39."}, {"Citation": "Thacker G., Kumar Y., Khan M. P., Shukla N., Kapoor I., Kanaujiya J. K., \u2026 Trivedi A. K. Skp2 inhibits osteogenesis by promoting ubiquitin-proteasome degradation of Runx2. Biochimica et Biophysica Acta/General Subjects 2016;1863:510-519."}, {"Citation": "Tome-Carneiro J., Larrosa M., Gonzalez-Sarrias A., Tomas-Barberan F. A., Garcia-Conesa M. T., Espin J. C. Resveratrol and clinical trials: The crossroad from in vitro studies to human evidence. Current Pharmaceutical Design 2013;19:6064-6093."}, {"Citation": "Tsang C. K., Liu Y., Thomas J., Zhang Y., Zheng X. F. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nature Communications 2014;5:3446."}, {"Citation": "Wang B., Kohli J., Demaria M. Senescent cells in cancer therapy: Friends or foes? Trends Cancer. 2020."}, {"Citation": "Weydert C. J., Cullen J. J. Measurement of superoxide dismutase, catalase, and glutathione peroxidase in cultured cells and tissue. Nature Protocols 2010;5:51-66."}, {"Citation": "Wu D., Yotnda P. Production and detection of reactive oxygen species (ROS) in cancers. Journal of Visualized Experiments: JoVE 2011."}, {"Citation": "Yi Z. C., Liu Y. Z., Li H. X., Wang Z. Prooxidant action of chebulinic acid and tellimagrandin I: Causing copper-dependent DNA strand breaks. Toxicology in Vitro 2009;23:425-431."}, {"Citation": "Yousuf, M., Shamsi, A., Khan, P., Shahbaaz, M., AlAjmi, M. F., Hussain, A., \u2026 Hassan, M. I. (2020). Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. International Journal of Molecular Science, 21(10), 3526."}, {"Citation": "Yu, K. D., Zhu, R., Zhan, M., Rodriguez, A. A., Yang, W., Wong, S., \u2026 Chang, J. C. (2013). Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer. Clinical Cancer Research, 19, 2723-2733."}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "4", "Day": "2"}, {"Year": "2020", "Month": "8", "Day": "17"}, {"Year": "2020", "Month": "9", "Day": "7"}, {"Year": "2020", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "9", "Hour": "12", "Minute": "34"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32902904", "10.1002/cbin.11463"]}}]}